Dexcom Inc: (NASD: DXCM)
$20.27
-0.09 (-0.44%)
Volume 566,611
May 23 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 19.99 - 20.42 |
| 52wk Low - High | 10.26 - 21.69 |
| Previous Close | 20.36 |
| Avg. Volume | 778,256 |
| Industry | MED INSTRUMENTS |
| Market Cap | 1.42 B |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.87 |
| PE (Forward) | 0.00 |
| Current Year Est. | -0.54 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
121 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | -0.54 |
| Current Quarter Estimate | -0.16 |
| Most Accurate Estimate | -0.16 |
| Earnings ESP |
0.00% |
| Next Earnings Report Date | 08-05-2013 |
| EPS Last Year | -0.76 |
| Expected Earnings Growth | 32.50% |
Company Description
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | -0.16 | -0.13 | -0.54 | -0.21 |
| Number of Estimates | 9 | 9 | 10 | 9 |
| Low Estimate | -0.17 | -0.17 | -0.63 | -0.37 |
| High Estimate | -0.14 | -0.09 | -0.42 | NA |
| Year Ago EPS | -0.21 | -0.25 | -0.81 | -0.54 |
| EPS Growth | 24.87% | 48.00% | 33.33% | 60.70% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| DEXCOM INC | DXCM | 20.36 | |
|
| NATUS MEDICAL | BABY | 14.05 | |
|
| CRYOLIFE INC | CRY | 6.31 | |
|
| DELCATH SYS INC | DCTH | 0.42 | |
|
| GLOBUS MEDICAL | GMED | 15.29 | |
|
| HEARTWARE INTL | HTWR | 92.81 | |
|
| INTUITIVE SURG | ISRG | 470.30 | |
|
| MELA SCIENCES | MELA | 1.08 | |
|
| OXYSURE SYSTEMS | OXYS | 0.81 | |
|
| PACIFIC BIOSCI | PACB | 2.45 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
DexCom Stays at Neutral
May 23, 2013
DexCom Loss Narrower than Est.
May 02, 2013
Reiterate DexCom at Neutral
Mar 04, 2013
DexCom Reduces Losses in 4Q, Rev Up
Feb 22, 2013
Earnings Preview: Medtronic
Feb 15, 2013
Still Neutral on DexCom
Nov 15, 2012
DexCom Continues to Incur Loss
Nov 05, 2012
FDA Nod for Dexcom G4 Platinum
Oct 11, 2012
Financials
| EPS TTM | -0.76 |
| Sales | 100 |
| Net Income | -52 |
| Price/Earnings | NA |
| Price/Book | 19.25 |
| Price/Cash Flow | NA |
| Price/Sales | 12.94 |
News
DexCom Makes a Move: Down 1.8% - Financial News Network Online - Market Movers
May 23, 2013
Short-term Underperformance Detected in Shares of ABIOMED in the Health Care Equipment Industry (ABMD, EW, DXCM, WMGI, BCR) - Financial News Network Online - News Corner
May 22, 2013
DexCom (DXCM) Showing Bullish Technicals But Could Fall Through $20.62 Support - Freshbrewedmedia
May 21, 2013
DexCom Earnings Hindsight: Up 25.3% in Last 19 Days (DXCM) - Comtex Smartrend(R)
May 20, 2013
Recent 52-Week High Exceeded in Shares of DexCom (DXCM) - Financial News Netwfork Online - 52-Week High-Lows
May 20, 2013
Post Earnings Update: DexCom Has Climbed 25.3% Higher in Past 2 Weeks (DXCM) - Financial News Network Online - Earnings Lookback
May 18, 2013
DexCom Shares Climbing Higher, Up 1.6% - Financial News Network Online - Market Movers
May 17, 2013
DexCom: 52-Week High Recently Eclipsed (DXCM) - Financial News Netwfork Online - 52-Week High-Lows
May 17, 2013
Broker Recommendations
| Current ABR | 1.85 |
| ABR (Last Week) | 1.85 |
| # of recs in ABR | 13 |
| Average Target Price | 18.14 |
| Industry Rank by ABR | 121 out of 265 |
| Rank in Industry | 10 out of 54 |
